Answers are grounded in this paper and cite their sources.
These studies elucidate the complexity of immune checkpoint regulation in the tumor microenvironment, identifying multiple factors likely contributing to coordinated immunosuppression. These factors may provide tumor escape mechanisms from anti-PD-1/PD-L1 therapy, and should be considered for cotargeting in combinatorial immunomodulation treatment strategies.
No takes yet. Share an insight, caveat, or question.
Taube et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: